Samsung Biologics
207940.KS
#399
Rank
C$71.18 B
Marketcap
$1,000
Share price
0.00%
Change (1 day)
31.30%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2024 (TTM): C$1.63 Billion

According to Samsung Biologics 's latest financial reports the company's current earnings are C$3.13 Billion. In 2023 the company made an earning of C$1.26 Billion, an increase over its 2022 earnings that were of C$1.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$1.63 B28.81%
2023 C$1.26 B9.77%
2022 C$1.15 B67.66%
2021 C$0.68 B103.97%
2020 C$0.33 B57.39%
2019 C$0.21 B-45.46%
2018 C$0.39 B-390%
2017 -C$0.14 Billion-46.74%
2016 -C$0.26 Billion